TM

Tapan Maniar

Founder of Aiolos Bio

Cambridge, Massachusetts

Overview

Work Experience

AB

Aiolos Bio

  • Chief Business Officer & Co-Founder

    2023 - Current

EB

Emalex Biosciences

  • Board Observer

    2022 - 2023

RP

Rivus Pharmaceuticals

  • Board Observer

    2022 - 2023

BC

Bain Capital

  • Principal

    2021 - 2023

G

Genentech

  • Genentech Head of BD for Tech Platforms | Pharma Partnering

    2017 - 2021

    Led Genentech's BD efforts to access research technology platforms and novel modalities across therapeutic areas. Executed numerous discovery/pre-clinical stage collaborations, clinical-stage partnerships, and an M&A. Notable transactions include: Heptares (GPCR targeting), Scenic Biotech (Genetic Modifiers), X-Chem (DEL for Oncology), Skyhawk Tx (SM RNA splicing), Ribometrix (RNA modulation), Genesis Tx (ML for small molecules) and Prescient Design (ML for large molecules).

M&

McKinsey & Company

  • Engagement Manager

    2015 - 2017

  • Associate

    2013 - 2014

TR

The Rockefeller University

  • Graduate Student

    2004 - 2011

RU

Rockefeller University

  • Summer Research Assistant (SURF Program)

    2003 - 2003

BC

Bard College

  • Research Assistant (ISROP Program)

    2001 - 2003

Education

Relevant Websites